Table 5. Summary of evidence by cancer type.
| Cancer type | In vitro | In vivo | Case report/Trial |
|---|---|---|---|
| Breast | [26, 27, 39, 93] | [31, 32, 34] | |
| CLL | [14] | [14] | |
| Colorectal | [23, 25, 33] | [19, 21, 23, 25, 47] | NCT02998736 |
| EAC | [52] | ||
| Gastric | [18] | ||
| Glioma | [33] | [26, 27] |
NCT02279992 NCT01817751 |
| HNSCC | [48] | [48] | [61, 62] NCT03238365 NCT02544880 |
| Liver (hepatocellular carcinoma) | [33, 47] | [47] | |
| Lung cancer | [40, 42, 45] | [40, 42] | |
| Lymphatic malformations | NCT02335242 | ||
| Lymphoma | [20] | [20, 21, 46] | |
| Medulloblastoma | [28, 29, 33] | ||
| Melanoma | [35] | [64] | |
| MM | [37] | [37] | [59] NCT01858558 |
| Myelodysplastic syndrome | NCT03259516 | ||
| Pancreatic | [36] |
NCT01903083 NCT01342224 |
|
| Penile squamous cell carcinoma | [58] | ||
| Prostate | [17] | [22, 17] | |
| RMS | [51] | [51] | |
| Thyroid | [49] | ||
| Waldenstrom’s macroglobulinemia | [53, 54] |